Please check your internet connection and try again.
# Ecospirin Enteric-Coated (Aspirin Enteric-Coated)
## Overview
Ecospirin Enteric-Coated is a brand of aspirin, a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, antipyretic, and antiplatelet properties. The enteric coating is designed to prevent dissolution in the stomach and delay absorption until it reaches the small intestine, which may reduce gastric irritation.
## Primary Indications
* Pain and fever
* Inflammatory conditions (e.g., rheumatoid arthritis)
* Prevention of cardiovascular events (e.g., myocardial infarction, stroke) in patients with established cardiovascular disease or risk factors (secondary prevention).
* Prevention of preeclampsia in specific high-risk pregnant individuals.
## Adult Dosing
* **Analgesic/Antipyretic/Anti-inflammatory:**
* 325 mg to 650 mg orally every 4 to 6 hours as needed.
* Maximum: 4000 mg per day.
* **Cardiovascular Prevention (Secondary Prevention):**
* Typically 75 mg to 162 mg orally once daily. Higher doses may be used in specific situations, but often lower doses are preferred for long-term use to minimize bleeding risk.
* **Cardiovascular Prevention (Primary Prevention):**
* Dosing varies based on risk assessment and guidelines. Common doses range from 75 mg to 162 mg orally once daily. The decision to initiate aspirin for primary prevention is individualized and based on cardiovascular risk factors.
* **Preeclampsia Prevention:**
* 81 mg orally once daily starting between 12 and 16 weeks of gestation and continuing until delivery.
**Note:** Specific dosing for cardiovascular prevention and preeclampsia prevention should adhere to current clinical guidelines and prescriber protocols.
## Pediatric Dosing
Aspirin is generally **NOT recommended** for children and teenagers due to the risk of Reye's syndrome, a rare but serious illness, especially during viral infections like influenza or chickenpox. If aspirin is deemed absolutely necessary, it should be under strict medical supervision, and dosing would be weight-based.
* **General Analgesic/Antipyretic (Rarely used, under strict medical supervision):**
* **50-100 mg/kg/day orally divided every 4 to 6 hours.**
* **Maximum: 4000 mg per day.**
**Caution:** Avoid in children and adolescents with viral infections or suspected viral infections.
## Dose Adjustments
* **Renal Impairment:** Use with caution. Dose reduction may be necessary in severe renal impairment.
* **Hepatic Impairment:** Use with caution.
## Contraindications
* Hypersensitivity to aspirin, other salicylates, or NSAIDs.
* Children and teenagers with viral infections.
* Active peptic ulceration or history of recurrent peptic ulcers.
* Bleeding disorders (e.g., hemophilia).
* Severe hepatic or renal impairment.
* Severe heart failure.
* Late pregnancy (third trimester).
## Adverse Effects
* **Gastrointestinal:** Dyspepsia, heartburn, nausea, vomiting, abdominal pain, GI bleeding, ulceration.
* **Hematologic:** Increased bleeding time, bruising, epistaxis, petechiae.
* **Hypersensitivity:** Bronchospasm, urticaria, angioedema.
* **Other:** Tinnitus, hearing loss (especially with higher doses), dizziness, confusion.
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, DOACs):** Increased risk of bleeding.
* **Other NSAIDs (including COX-2 inhibitors):** Increased risk of GI toxicity and bleeding.
* **Corticosteroids:** Increased risk of GI ulceration and bleeding.
* **Alcohol:** Increased risk of GI bleeding.
* **Methotrexate:** Increased methotrexate toxicity due to decreased renal clearance.
* **Uricosuric agents (e.g., probenecid):** May decrease the efficacy of uricosuric agents.
* **Antihypertensives (e.g., ACE inhibitors, ARBs, beta-blockers, diuretics):** Aspirin may reduce their antihypertensive effect.
## Monitoring
* Signs and symptoms of GI bleeding (melena, hematemesis, abdominal pain).
* Signs of bleeding or bruising.
* Renal and hepatic function, especially with long-term use or in patients with pre-existing impairment.
* Tinnitus or hearing changes, which may indicate toxicity.
## Clinical Pearls
* The enteric coating helps reduce gastric irritation but does not eliminate the risk of GI bleeding or ulceration. Taking with food may still be beneficial for some.
* Crushing or chewing enteric-coated tablets negates the enteric coating effect, increasing the risk of gastric irritation and should be avoided.
* For patients requiring low-dose aspirin for cardiovascular prevention, a dose of 75 mg to 162 mg daily is typically used.
* Aspirin's antiplatelet effect is irreversible and lasts for the life of the platelet (7-10 days). Discontinuation for surgery requires careful consideration of bleeding risk versus thrombotic risk.
***
*This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines for complete and up-to-date details before making treatment decisions.*
